Browse by ["viewname_eprint_publisher" not defined]

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Creators | Item Type | No Grouping
Jump to: B | D | G | H | K | L | M | N | P | R | S | T | V | W
Number of items at this level: 38.

B

Beier, D. and Proescholdt, M. and Reinert, C. and Hattingen, E. and Seidel, C. and Dirven, L. and Luerding, R. and Pfister, S. and Pietsch, T. and Hau, P. (2017) MULTICENTER PILOT STUDY OF RADIO-CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR ADULTS WITH MEDULLOBLASTOMA - THE NOA-07 TRIAL. OXFORD UNIV PRESS INC, CARY.

Beier, Dagmar and Proescholdt, Martin and Pietsch, Torsten and Jones, David and Pfister, Stefan M. and Hattingen, Elke and Dirven, Linda and Luerding, Ralf and Weller, Michael and Kortman, Rolf-Dieter and Bogdahn, Ulrich and Hau, Peter (2017) MULTICENTER PILOT STUDY OF RADIO-CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR ADULTS WITH MEDULLOBLASTOMA - THE NOA-07 TRIAL. OXFORD UNIV PRESS INC, CARY.

Berghoff, A. S. and Woehrer, A. and Hackl, M. and Pichler, J. and Hutterer, M. and Widhalm, G. and Dieckmann, K. and Prayer, D. and Hainfellner, J. A. and Preusser, M. (2014) DENSITY OF TUMOR INFILTRATING LYMPHOCYTES CORRELATES WITH BRAIN EDEMA AND OVERALL SURVIVAL IN BRAIN METASTASES. OXFORD UNIV PRESS INC, CARY.

Bogdahn, Ulrich and Stockhammer, Guenter and Mahapatra, Ashok and Hau, Peter and Schuknecht, Bernhard and van den Bent, Martin and Heinrichs, Hubert (2012) PSEUDOPROGRESSION IN PATIENTS WITH HIGH-GRADE GLIOMA OF A PHASE IIB STUDY WITH TRABEDERSEN. NEURO-ONCOLOGY, 14 (suppl6). vi68. ISSN 1522-8517

D

Delic, Sabit and Lottmann, Nadine and Stelzl, Anja and Liesenberg, Franziska and Wolter, Marietta and Goetze, Silke and Zapatka, Marc and Shiio, Yuzuru and Sabel, Michael C. and Felsberg, Joerg and Reifenberger, Guido and Riemenschneider, Markus J. (2014) MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation. NEURO-ONCOLOGY, 16 (2). pp. 179-190. ISSN 1522-8517, 1523-5866

G

Galldiks, N. and Dunkl, V. and Stoffels, G. and Hutterer, M. and Rapp, M. and Kebir, S. and Goldbrunner, R. and Ruge, M. I. and Schmidt, M. and Langen, K. (2014) DIAGNOSIS OF PSEUDOPROGRESSION IN PATIENTS WITH GLIOBLASTOMA USING AMINO ACID PET. OXFORD UNIV PRESS INC, CARY.

Galldiks, Norbert and Dunkl, Veronika and Stoffels, Gabriele and Hutterer, Markus and Rapp, Marion and Kebir, Sied and Goldbrunner, Roland and Ruge, Maximilian I. and Schmidt, Matthias and Langen, Karl-Josef (2014) DIAGNOSIS OF PSEUDOPROGRESSION IN PATIENTS WITH GLIOBLASTOMA USING AMINO ACID PET. OXFORD UNIV PRESS INC, CARY.

Gawrisch, V. and Patwary, N. and Ruettgers, M. and Kerkhoff, E. and Riemenschneider, M. J. and Bogdahn, U. and Vollmann-Zwerenz, A. and Klein, C. A. and Hau, P. (2014) IN SITU ORGANOTYPIC SLICE CULTURE MIGRATION MODEL TO DISSECT INFILTRATIVE FROM STATIONARY HUMAN BRAIN TUMOR INITIATING CELLS. OXFORD UNIV PRESS INC, CARY.

Glas, M. and Scheffler, B. and Lazaridis, L. and Herrlinger, U. and Pierscianek, D. and Sure, U. and Proescholdt, M. and Hau, P. and Hense, J. and Kleinschnitz, C. and Grosu, A. and Stuschke, M. and Kebir, S. (2018) PRICOTTF: A PHASE I/II TRIAL OF TUMOR TREATING FIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA. OXFORD UNIV PRESS INC, CARY.

Glas, Martin and Scheffler, Bjoern and Lazaridis, Lazaros and Herrlinger, Ulrich and Pierscianek, Daniela and Sure, Ulrich and Proescholdt, Martin and Hau, Peter and Hense, Joerg and Kleinschnitz, Christoph and Grosu, Anca-Ligia and Stuschke, Martin and Kebir, Sied (2018) PriCoTTF: A PHASE I/II TRIAL OF TUMOR TREATING FIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA. OXFORD UNIV PRESS INC, CARY.

Goschzik, T. and zur Muehlen, A. and Doerner, E. and Waha, A. and Friedrich, C. and Hau, P. and Pietsch, T. (2019) GENOMIC LANDSCAPE OF MEDULLOBLASTOMA IN ADULTS. OXFORD UNIV PRESS INC, CARY.

Goschzik, Tobias and Muehlen, Anja Zur and Doerner, Evelyn and Waha, Andreas and Friedrich, Carsten and Hau, Peter and Pietsch, Torsten (2019) GENOMIC LANDSCAPE AND BIOLOGY OF MEDULLOBLASTOMA IN ADULTS. OXFORD UNIV PRESS INC, CARY.

H

Happold, Caroline and Felsberg, Joerg and Clarke, Jennifer and Soffietti, Riccardo and Marosi, Christine and Krex, Dietmar and Ducray, Francois and Hau, Peter and Reijneveld, Jaap and Weyerbrock, Astrid and Wick, Antje and Reardon, David and Glas, Martin and Razis, Evangelia and Herrlinger, Ulrich and Tonn, Joerg-Christian and Carpentier, Antoine F. and Lefranc, Florence and Le Rhun, Emilie and Verschuere, Tina and Golfinopoulos, Vassilis and Klein, Martin and Reifenberger, Guido and Weller, Michael (2017) MOLECULAR GENETIC, HOST-DERIVED AND CLINICAL DETERMINANTS OF LONG-TERM SURVIVAL IN GLIOBLASTOMA: FIRST RESULTS FROM THE BRAIN TUMOR FUNDERS' COLLABORATIVE CONSORTIUM. OXFORD UNIV PRESS INC, CARY.

Happold, Caroline and Soffietti, Riccardo and Marosi, Christine and Reijneveld, Jaap and Schackert, Gabriele and Weyerbrock, Astrid and Clarke, Jennifer and Ducray, Francois and Hau, Peter and Carpentier, Antoine and Felsberg, Jorg and Roth, Patrick and Golfinopoulos, Vassilis and Klein, Martin and Reifenberger, Guido and Weller, Michael (2016) MOLECULAR GENETIC, HOST-DERIVED AND CLINICAL DETERMINANTS OF LONG-TERM SURVIVAL IN GLIOBLASTOMA: AN UPDATE FROM THE BRAIN TUMOR FUNDERS' COLLABORATIVE CONSORTIUM. OXFORD UNIV PRESS INC, CARY.

Herrlinger, U. and Schaefer, N. and Steinbach, J. P. and Weyerbrock, A. and Hau, P. and Goldbrunner, R. and Leutgeb, B. and Urbach, H. and Stummer, W. and Glas, M. (2014) THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS: FINAL SURVIVAL RESULTS AND QUALITY OF LIFE. OXFORD UNIV PRESS INC, CARY.

Herrlinger, Ulrich and Tzaridis, Theophilos and Mack, Frederic and Steinbach, Joachim and Schlegel, Uwe and Sabel, Michael and Hau, Peter and Kortman, Rolf-Dieter and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Schnell, Oliver and Baehr, Oliver and Uhl, Martin and Tabatabai, Ghazaleh and Ringel, Florian and Schmidt-Graf, Friederike and Brehmer, Stefanie and Weyerbrock, Astrid and Bullinger, Lars and Vajkoczy, Peter and Vatter, Hartmut and Schaefer, Niklas and Kebir, Sied and Weller, Johannes and Stummer, Walter and Simon, Matthias and Keil, Vera and Nelles, Michael and Fimmers, Rolf and Pietsch, Torsten and Hattingen, Elke and Coch, Christoph and Glas, Martin (2017) PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial. OXFORD UNIV PRESS INC, CARY.

Hutterer, Markus and Krenn, Yvonne and Kunz, Alexander and McCoy, Marc and Egger, Barbara and Schroeder, Michael and Wendl, Christina and Marienhagen, Joerg and Fritsch, Brita and Urbach, Horst and Meyer, Philipp T. and Galldiks, Norbert and Langen, Karl-Josef and Hau, Peter and Trinka, Eugen (2014) INCREASED CEREBRAL AMINO ACID UPTAKE DURING AND AFTER EPILEPTIC DISORDERS MIMICS BRAIN TUMOR IN F-18-FET PET. OXFORD UNIV PRESS INC, CARY.

K

Kebir, S. and Schaefer, N. and Hattingen, E. and Steinbach, J. and Weyerbrock, A. and Hau, P. and Goldbrunner, R. and Proescholdt, M. and Herrlinger, U. and Glas, M. (2017) EFFECT OF AGE ON OUTCOME IN THE GLARIUS TRIAL. OXFORD UNIV PRESS INC, CARY.

Kebir, S. and Stummer, W. and Steinbach, J. P. and Weyerbrock, A. and Hau, P. and Goldbrunner, R. and Proescholdt, M. and Vatter, H. and Herrlinger, U. and Glas, M. (2017) COMPLETE RESECTION IS NOT ASSOCIATED WITH IMPROVED SURVIVAL IN MGMT NON-METHYLATED GLIOBLASTOMA. RESULTS FROM THE GLARIUS TRIAL. OXFORD UNIV PRESS INC, CARY.

Kebir, Sied and Hattingen, Elke and Schaub, Christina and Schafer, Niklas and Steinbach, Joachim and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Tzaridis, Theophilos and Baehr, Oliver and Proescholdt, Martin and Glas, Martin and Herrlinger, Ulrich (2016) EFFECT OF AGE ON OUTCOME IN THE GLARIUS TRIAL. OXFORD UNIV PRESS INC, CARY.

Kebir, Sied and Lazaridis, Lazaros and Schmidt, Teresa and Oster, Christoph and Pierscianek, Daniela and Guberina, Nika and Kleinschnitz, Christoph and Proescholdt, Martin and Hau, Peter and Grosu, Anca-Ligia and Sure, Ulrich and Scheffler, Bjoern and Stuschke, Martin and Glas, Martin (2020) PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA. In: 25th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO), NOV 19-21, 2020, Virtuell.

Kebir, Sied and Stummer, Walter and Steinbach, Joachim and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Proescholdt, Martin and Vatter, Hartmut and Herrlinger, Ulrich and Glas, Martin (2017) COMPLETE RESECTION IS NOT ASSOCIATED WITH IMPROVED SURVIVAL IN MGMT NON-METHYLATED GLIOBLASTOMA: RESULTS FROM THE GLARIUS TRIAL. OXFORD UNIV PRESS INC, CARY.

L

Leidgens, V. J. and Alieva, M. and Lu, X. and Patwary, N. and Kerkhoff, E. and Proescholdt, M. J. M. and Vollmann-Zwerenz, A. and van Rheenen, J. and Klein, C. A. and Hau, P. (2017) CHARACTERISATION OF HUMAN BRAIN TUMOUR INITIATING CELLS LEADING INVASION. OXFORD UNIV PRESS INC, CARY.

Leidgens, Verena and Alieva, Maria and Lu, Xin and Patwary, Nina and Kerkhoff, Eugen and Proescholdt, Martin and Vollmann-Zwerenz, Arabel and Van Rheenen, Jacco and Klein, Christoph and Hau, Peter (2017) CHARACTERISATION OF INVASION OF HUMAN BRAIN TUMOUR INITIATING CELLS IN HUMAN GLIOBLASTOMA. OXFORD UNIV PRESS INC, CARY.

Leukel, Petra and Seliger, Corinna and Vollmann, Arabel and Jachnik, Birgit and Bogdahn, Ulrich and Hau, Peter (2011) WARBURG EFFECT INFLUENCES MIGRATION OF HIGH-GRADE GLIOMA IN VITRO THROUGH ENHANCED TGF-BETA2 ACTIVATION BY THROMBOSPONDIN-1. NEURO-ONCOLOGY, 13 (Suppl3): MP-04. iii69. ISSN 1522-8517

M

Moeckel, Sylvia and Meyer, Katharina and Bosserhoff, Anja and Spang, Rainer and Leukel, Petra and Vollmann, Arabel and Jachnick, Birgit and Stangl, Christina and Proescholdt, Martin and Bogdahn, Ulrich and Hau, Peter (2011) PREDICTION OF THERAPY RESPONSE IN SHORT-TERM TREATED PRIMARY TUMOR-INITIATING CELLS IN VITRO. NEURO-ONCOLOGY, 13 (suppl3): CB-40. iii18-iii19. ISSN 1522-8517

N

Nowosielski, M. and Kremser, C. and Schocke, M. and Gizewski, E. and Iglseder, S. and Muigg, A. and Freyschlag, C. and Stockhammer, G. and Hutterer, M. (2014) DCE-MRI DISCRIMINATES BETWEEN RESPONDER AND NON-RESPONDER IN RECURRENT HIGH-GRADE GLIOMA PATIENTS UNDERGOING ANTI-ANGIOGENIC TREATMENT. OXFORD UNIV PRESS INC, CARY.

P

Pietsch, Torsten and Goschzik, Tobias and Gessi, Marco and Waha, Andreas and Hau, Peter (2016) GENOMIC LANDSCAPE OF ADULT MEDULLOBLASTOMAS CLASSIFIED ACCORDING TO WHO 2016 GUIDELINES. OXFORD UNIV PRESS INC, CARY.

Proescholdt, Martin and Doenitz, Christian and Shiban, Youssef and Hau, Peter and Putnik, Kurt and Andreas, Muehlberger (2017) FINDING A PREDICTIVE MARKER FOR COMPLIANCE TO TTFIELDS THERAPY - THE COMPTUNE STUDY. OXFORD UNIV PRESS INC, CARY.

Proescholdt, Martin and Onken, Julia and Hau, Peter and Doenitz, Christian and Misch, Martin (2017) TTFIELDS FOR NEWLY DIAGNOSED GLIOBLASTOMA: IMPACT OF CONSULTATION STRATEGY. OXFORD UNIV PRESS INC, CARY.

R

Riemenschneider, Markus and Rudolf, Andras and Hau, Peter and Pukrop, Tobias and Koelbl, Oliver and Corbacioglu, Selim and Brawanski, Alexander and Proescholdt, Martin and Lorenz, Julia (2019) A TARGETED NGS-BASED OVERALL SOLUTION TO SUPPORT DIAGNOSTICS AND THERAPY PREDICTION IN NEUROONCOLOGY: CONSIDERATIONS FOR A FLEXIBLE AND COST-EFFICIENT PLATFORM CHOICE AND PANEL DESIGN. OXFORD UNIV PRESS INC, CARY.

S

Schlingensiepen, Karl-Hermann and Bogdahn, U. and Stockhammer, G. and Mahapatra, A. K. and Venkataramana, N. K. and Oliushine, V. and Parfenov, V. and Poverennova, I. and Hau, P. and Jachimczak, P. and Heinrichs, H. (2011) RESPONSE PATTERNS OF HIGH-GRADE GLIOMA PATIENTS TREATED WITH THE TGF-BETA2 INHIBITOR TRABEDERSEN IN A RANDOMIZED PHASE IIB STUDY. NEURO-ONCOLOGY, 13 (Suppl3): NO-21. iii45. ISSN 1522-8517

Sefranek, D. and Wendl, C. and Hutterer, M. and Hau, P. and Uhl, M. (2014) EFFECTS OF GLIOBLASTOMA FIRST-LINE TRIALS ON TIME DELAY TO INITIATION OF TREATMENT, SIGNS OF EARLY TUMOR PROGRESSION AND PROGRESSION-FREE SURVIVAL. OXFORD UNIV PRESS INC, CARY.

Seidel, C. and Reimers, C. and Beier, D. and Pietsch, T. and Warmuth-Metz, M. and Bogdahn, U. and Kortmann, R. and Hau, P. (2016) FEASIBILITY AND TOXICITY OF CONCOMITANT RADIOCHEMOTHERAPY WITH VINCRISTINE IN ADULT PATIENTS WITH MEDULLOBLASTOMA - RESULTS FROM THE NOA-07 TRIAL. OXFORD UNIV PRESS INC, CARY.

Seliger, C. and Renner, K. and Kreutz, M. and Meyer, A. and Jachnik, B. and Bogdahn, U. and Vollmann-Zwerenz, A. and Hau, P. (2014) TURN OLD INTO NEW: METFORMIN AS ANTINEOPLASTIC AGENT IN GLIOBLASTOMA. OXFORD UNIV PRESS INC, CARY.

T

Tzaridis, Theophilos and Schaefer, Niklas and Weller, Johannes and Steinbach, Joachim and Seidel, Sabine and Schlegel, Uwe and Sabel, Michael and Hau, Peter and Seidel, Clemens and Krex, Dietmar and Goldbrunner, Roland and Tonn, Joerg-Christian and Grauer, Oliver and Schaub, Christina and Coch, Christoph and Glas, Martin and Pietsch, Torsten and Fimmers, Rolf and Reifenberger, Guido and Felsberg, Joerg and Herrlinger, Ulrich (2019) MGMT PROMOTER METHYLATION ANALYSIS FOR ALLOCATING COMBINED CCNU/TMZ CHEMOTHERAPY: LESSONS LEARNED FROM THE CeTeG/NOA-09 TRIAL. OXFORD UNIV PRESS INC, CARY.

V

Vollmann-Zwerenz, Arabel and Velez-Char, Natalia and Jachnik, Birgit and Ramm, Paul and Leukel, Petra and Bogdahn, Ulrich and Hau, Peter (2011) CHARACTERIZATION OF BRAIN TUMOR-INITIATING CELLS AND HUMAN NEURAL PROGENITORS WITH RESPECT TO EXPRESSION OF EMT-ASSOCIATED PROTEINS STAT-3 AND C/EBP beta. NEURO-ONCOLOGY, 13 (Suppl3): SC-14. iii148. ISSN 1522-8517

W

Weller, Johannes and Tzaridis, Theophilos and Steinbach, Joachim and Schlegel, Uwe and Hau, Peter and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Baehr, Oliver and Uhl, Martin and Seidel, Clemens and Tabatabai, Ghazaleh and Bullinger, Lars and Galldiks, Norbert and Schaub, Christina and Stummer, Walter and Simon, Matthias and Fimmers, Rolf and Matthias, Schmid and Coch, Christoph and Glas, Martin and Herrlinger, Ulrich and Schaefer, Niklas (2018) QUALITY OF LIFE IN THE PHASE III CeTeG/NOA-09 TRIAL RANDOMIZING CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA. OXFORD UNIV PRESS INC, CARY.

This list was generated on Sat Aug 1 20:00:41 2026 CEST.